Suchergebnisse - "Hellmann, Mark A"

PubPharm (25)

1

Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2023

von Lotan, I. | Chen, J. | Hacohen, Y. | +17

2

Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis

enthalten in: PloS one | 2023

von Wilf-Yarkoni, A. | Feldmann, K. | Rubarth, K. | +14

3

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis

enthalten in: Scientific reports | 2022

von Stiebel-Kalish, H. | Rubarth, K. | Shouchane-Blum, K. | +12

ErratumIn: Sci Rep. 2023 Feb 20;13(1):2944. - PMID 36807557

4

Details and outcomes of a large cohort of MOG-IgG associated optic neuritis

enthalten in: Multiple sclerosis and related disorders | 2022

von Chen, J. | Flanagan, E. | Bhatti, M. | +21

5

Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

enthalten in: JAMA neurology | 2022

von Chen, J. | Huda, S. | Hacohen, Y. | +30

6

Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis

enthalten in: Neuromuscular disorders : NMD | 2022

von Lotan, I. | Hellmann, M. | Friedman, Y. | +3

7

OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis : RNFL thickening in acute optic neuritis from MOGAD vs MS

enthalten in: Multiple sclerosis and related disorders | 2022

von Chen, J. | Sotirchos, E. | Henderson, A. | +22

8

Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis : An Israeli Multi-Center Experience Following 3 Vaccine Doses

enthalten in: Frontiers in immunology | 2022

von Milo, R. | Staun-Ram, E. | Karussis, D. | +33

9

Exacerbation of myasthenia gravis following corticosteroid treatment : what is the evidence? A systematic review

enthalten in: Journal of neurology | 2021

von Lotan, I. | Hellmann, M. | Wilf-Yarkoni, A. | +1

10

Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS) : Early experience from a tertiary MS center in Israel

enthalten in: European journal of neurology | 2021

von Lotan, I. | Wilf-Yarkoni, A. | Friedman, Y. | +3